Therapeutics development for spinal muscular atrophy (original) (raw)

• Pearn J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.J Med Genet 15: 409–413, 1978.
  Article PubMed CAS Google Scholar
• McAndrew PE, Parsons DW, Simard LR et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.Am J Hum Genet 60: 1411–1422, 1997.
  Article PubMed CAS Google Scholar
• Munsat TL, Davies KE. International SMA consortium meeting. (26–28 June 1992, Bonn, Germany).Neuromuscul Disord 2: 423–428, 1992
  Article PubMed CAS Google Scholar
• Zerres K, Rudnik-Schonebom S. Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications.Arch Neurol 52: 518–523, 1995.
  Article PubMed CAS Google Scholar
• Crawford TO. Concerns about the design of clinical trials for spinal muscular atrophy.Neuromuscul Disord 14: 456–460, 2004
  Article PubMed Google Scholar
• Swoboda KJ, Prior TW, Scott CB et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function.Ann Neurol 57: 704–712, 2005.
  Article PubMed CAS Google Scholar
• Ince SWaPG. Pathology of motor neuron disorders. In: Motor Neuron Disorders (Strong PJSaMJ, ed), pp 17–49. Philadelphia: Butterworth Heinemann, 2003.
  Google Scholar
• Brzustowicz LM, Lehner T, Castilla LH et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.Nature 344: 540–541, 1990.
  Article PubMed CAS Google Scholar
• Melki J, Sheth P, Abdelhak S et al. Mapping of acute (type I) spinal muscular atrophy to chromosome 5ql2-ql4: The French Spinal Muscular Atrophy Investigators.Lancet 336: 271–273, 1990.
  Article PubMed CAS Google Scholar
• Lefebvre S, Burglen L, Reboullet S et al. Identification and characterization of a spinal muscular atrophy-determining gene.Cell 80: 155–165, 1995.
  Article PubMed CAS Google Scholar
• Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).Hum Mutat 15: 228–237, 2000.
  Article PubMed CAS Google Scholar
• Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.Proc Natl Acad Sci USA 96: 6307–6311, 1999.
  Article PubMed CAS Google Scholar
• Monani UR, Lorson CL, Parsons DW et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.Hum Mol Genet 8: 1177–1183, 1999.
  Article PubMed CAS Google Scholar
• Sumner CJ, Fischbeck, KH. Spinal muscular atrophy. In: Neurobiology of Disease (Gilman S, ed), San Diego: Elsevier (in press).
• Lorson CL, Strasswimmer J, Yao JM et al. SMN oligomerization defect correlates with spinal muscular atrophy severity.Nat Genet 19: 63–66, 1998.
  Article PubMed CAS Google Scholar
• Cifuentes-Diaz C, Frugier T, Tiziano FD et al. Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy.J Cell Biol 152: 1107–1114, 2001.
  Article PubMed CAS Google Scholar
• Lefebvre S, Burlet P, Liu Q et al. Correlation between severity and SMN protein level in spinal muscular atrophy.Nat Genet 16: 265–269, 1997.
  Article PubMed CAS Google Scholar
• Coovert DD, Le TT, McAndrew PE et al. The survival motor neuron protein in spinal muscular atrophy.Hum Mol Genet 6: 1205–1214, 1997.
  Article PubMed CAS Google Scholar
• Gavrilov DK, Shi X, Das K, Gilliam TC, Wang CH. Differential SMN2 expression associated with SMA severity.Nat Genet 20: 230–231, 1998.
  Article PubMed CAS Google Scholar
• Soler-Botija C, Cusco I, Caselles L, Lopez E, Baiget M, Tizzano EF. Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function?J Neuropathol Exp Neurol 64: 215–223, 2005.
  PubMed CAS Google Scholar
• Parsons DW, McAndrew PE, Iannaccone ST, Mendell JR, Burghes AH, Prior TW. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number.Am J Hum Genet 63: 1712–1723, 1998.
  Article PubMed CAS Google Scholar
• Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.Am J Hum Genet 70: 358–368, 2002.
  Article PubMed CAS Google Scholar
• Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ. Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2.Am J Med Genet A 130: 307–310, 2004.
  Article Google Scholar
• Parano E, Pavone L, Falsaperla R, Trifiletti R, Wang C. Molecular basis of phenotypic heterogeneity in siblings with spinal muscular atrophy.Ann Neurol 40: 247–251, 1996.
  Article PubMed CAS Google Scholar
• Sumner CJ, Huynh TN, Markowitz JA et al. Valproic acid increases SMN levels in spinal muscular atrophy patient cells.Ann Neurol 54: 647–654, 2003.
  Article PubMed CAS Google Scholar
• Liu Q, Fischer U, Wang F, Dreyfuss G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.Cell 90: 1013–1021, 1997.
  Article PubMed CAS Google Scholar
• Patrizi AL, Tiziano F, Zappata S, Donati MA, Neri G, Brahe C. SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis.Eur J Hum Genet 7: 301–309, 1999.
  Article PubMed CAS Google Scholar
• Paushkin S, Gubitz AK, Massenet S, Dreyfuss G. The SMN complex, an assemblyosome of ribonucleoproteins.Curr Opin Cell Biol 14: 305–312, 2002.
  Article PubMed CAS Google Scholar
• Friesen WJ, Massenet S, Paushkin S, Wyce A, Dreyfuss G. SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets.Mol Cell 7: 1111–1117, 2001.
  Article PubMed CAS Google Scholar
• Friesen WJ, Paushkin S, Wyce A et al. The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins.Mol Cell Biol 21: 8289–8300, 2001.
  Article PubMed CAS Google Scholar
• Yong J, Wan L, Dreyfuss G. Why do cells need an assembly machine for RNA-protein complexes?Trends Cell Biol 14: 226–232, 2004.
  Article PubMed CAS Google Scholar
• Will CL, Luhrmann R. Spliceosomal UsnRNP biogenesis, structure and function.Curr Opin Cell Biol 13: 290–301, 2001.
  Article PubMed CAS Google Scholar
• Gabanella F, Carissimi C, Usiello A, Pellizzoni L. The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation.Hum Mol Genet 14: 3629–3642. 2005
  Article PubMed CAS Google Scholar
• Wan L, Battle DJ, Yong J et al. The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy.Mol Cell Biol 25: 5543–5551, 2005.
  Article PubMed CAS Google Scholar
• Zhang HL, Pan F, Hong D, Shenoy SM, Singer RH, Bassell GJ. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization.J Neurosci 23: 6627–6637. 2003.
  PubMed CAS Google Scholar
• Rossoll W, Jablonka S, Andreassi C et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons.J Cell Biol 163: 801–812, 2003.
  Article PubMed CAS Google Scholar
• Sharma A, Lambrechts A, Hao LT et al. A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells.Exp Cell Res 309: 185–197, 2005
  Article PubMed CAS Google Scholar
• Chan YB, Miguel-Aliaga I, Franks C et al. Neuromuscular defects in a_Drosophila_ survival motor neuron gene mutant.Hum Mol Genet 12: 1367–1376, 2003.
  Article PubMed CAS Google Scholar
• McWhorter ML, Monani UR, Burghes AH, Beattie CE. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding.J Cell Biol 162: 919–931, 2003.
  Article PubMed CAS Google Scholar
• Winkler C, Eggert C, Gradl D et al. Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy.Genes Dev 19: 2320–2330, 2005.
  Article PubMed CAS Google Scholar
• Frugier T, Tiziano FD, Cifuentes-Diaz C et al. Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy.Hum Mol Genet 9: 849–858, 2000.
  Article PubMed CAS Google Scholar
• Hsieh-Li HM, Chang JG, Jong YJ et al. A mouse model for spinal muscular atrophy.Nat Genet 24: 66–70, 2000.
  Article PubMed CAS Google Scholar
• Monani UR, Sendtner M, Coovert DD et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.Hum Mol Genet 9: 333–339, 2000.
  Article PubMed CAS Google Scholar
• Le TT, Pham LT, Butchbach ME et al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.Hum Mol Genet 14: 845–857, 2005.
  Article PubMed CAS Google Scholar
• Kerr DA, Nery JP, Traystman RJ, Chau BN, Hardwick JM. Survival motor neuron protein modulates neuron-specific apoptosis.Proc Natl Acad Sci USA 97: 13312–13317, 2000.
  Article PubMed CAS Google Scholar
• Echaniz-Laguna A, Miniou P, Bartholdi D, Melki J. The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements.Am J Hum Genet 64: 1365–1370, 1999.
  Article PubMed CAS Google Scholar
• Monani UR, McPherson JD, Burghes AH. Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT).Biochim Biophys Acta 1445: 330–336, 1999.
  Article PubMed CAS Google Scholar
• Rouget R, Vigneault F, Codio C et al. Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cells.Biochem J 385: 433–443, 2005.
  Article PubMed CAS Google Scholar
• Baron-Delage S, Abadie A, Echaniz-Laguna A, Melki J, Beretta L. Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes.Mol Med 6: 957–968, 2000.
  PubMed CAS Google Scholar
• Majumder S, Varadharaj S, Ghoshal K, Monani U, Burghes AH, Jacob ST. Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene.J Biol Chem 279: 14803–14811, 2004.
  Article PubMed CAS Google Scholar
• Kemochan LE, Russo ML, Woodling NS et al. The role of histone acetylation in SMN gene expression.Hum Mol Genet 14: 1171–1182, 2005.
  Article Google Scholar
• Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H. Treatment of spinal muscular atrophy by sodium butyrate.Proc Natl Acad Sci USA 98: 9808–9813, 2001.
  Article PubMed CAS Google Scholar
• Brichta L, Hofmann Y, Hahnen E et al. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.Hum Mol Genet 12: 2481–2489, 2003.
  Article PubMed CAS Google Scholar
• Andreassi C, Angelozzi C, Tiziano FD et al. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy.Eur J Hum Genet 12: 59–65, 2004.
  Article PubMed CAS Google Scholar
• Brahe C, Vitali T, Tiziano FD et al. Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients.Eur J Hum Genet 13: 256–259, 2005.
  Article PubMed CAS Google Scholar
• Russman BS, Iannaccone ST, Samaha FJ. A phase 1 trial of riluzole in spinal muscular atrophy.Arch Neurol 60: 1601–1603. 2003.
  Article PubMed Google Scholar
• Miller RG, Moore DH, Dronsky V et al. A placebo-controlled trial of gabapentin in spinal muscular atrophy.J Neurol Sci 191: 127–131, 2001.
  Article PubMed CAS Google Scholar
• Merlini L, Solari A, Vita G et al. Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study.J Child Neurol 18: 537–541, 2003.
  Article PubMed Google Scholar
• Butchbach M, Le TT, Burghes AHM. Protective effects of butyrate analogues and prodrugs on a mouse model for spinal muscular atrophy.Neurosci Meeting 23: 27, 2004.
  Google Scholar
• Ryu H, Smith K, Camelo SI et al. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.J Neurochem 93: 1087–1093, 2005.
  Article PubMed CAS Google Scholar
• Grzeschik SM, Ganta M, Prior TW, Heavlin WD, Wang CH. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.Ann Neurol 58: 194–202, 2005.
  Article PubMed CAS Google Scholar
• Jarecki J, Chen X, Bernardino A et al. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.Hum Mol Genet 14: 2003–2018, 2005.
  Article PubMed CAS Google Scholar
• Lorson CL, Androphy EJ. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.Hum Mol Genet 9: 259–265, 2000.
  Article PubMed CAS Google Scholar
• Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.Nat Genet 30: 377–384, 2002.
  Article PubMed CAS Google Scholar
• Kashima T, Manley JL. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.Nat Genet 34: 460–463, 2003.
  Article PubMed CAS Google Scholar
• Hofmann Y, Lorson CL, Stamm S, Androphy EJ, Wirth B. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2).Proc Natl Acad Sci USA 97: 9618–9623, 2000.
  Article PubMed CAS Google Scholar
• Hofmann Y, Wirth B. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-betal.Hum Mol Genet 11: 2037–2049, 2002.
  Article PubMed CAS Google Scholar
• Young PJ, DiDonato CJ, Hu D, Kothary R, Androphy EJ, Lorson CL. SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1.Hum Mol Genet 11: 577–587, 2002.
  Article PubMed CAS Google Scholar
• Andreassi C, Jarecki J, Zhou J et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.Hum Mol Genet 10: 2841–2849, 2001.
  Article PubMed CAS Google Scholar
• Cartegni L, Krainer AR. Correction of disease-associated exon skipping by synthetic exon-specific activators.Nat Struct Biol 10: 120–125, 2003.
  Article PubMed CAS Google Scholar
• Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F. Bi-functional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.Proc Natl Acad Sci USA 100: 4114–4119, 2003.
  Article PubMed CAS Google Scholar
• Lunn MR, Root DE, Martino AM et al. Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism.Chem Biol 11: 1489–1493, 2004.
  Article PubMed CAS Google Scholar
• Wolstencroft EC, Mattis V, Bajer AA, Young PJ, Lorson CL. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.Hum Mol Genet 14: 1199–1210, 2005.
  Article PubMed CAS Google Scholar
• Chang HC, Hung WC, Chuang YJ, Jong YJ. Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin/ proteasome pathway.Neurochem Int 45: 1107–1112, 2004.
  Article PubMed CAS Google Scholar
• Haddad H, Cifuentes-Diaz C, Miroglio A, Roblot N, Joshi V, Melki J. Riluzole attenuates spinal muscular atrophy disease progression in a mouse model.Muscle Nerve 28: 432–437, 2003.
  Article PubMed CAS Google Scholar
• Lesbordes JC, Cifuentes-Diaz C, Miroglio A et al. Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy.Hum Mol Genet 12: 1233–1239, 2003.
  Article PubMed CAS Google Scholar
• Azzouz M, Le T, Ralph GS et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.J Clin Invest 114: 1726–1731, 2004.
  PubMed CAS Google Scholar
• Harper JM, Krishnan C, Darman JS et al. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats.Proc Natl Acad Sci USA 101: 7123–7128. 2004.
  Article PubMed CAS Google Scholar
• Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.Ann Neurol 53: 804–807, 2003.
  Article PubMed Google Scholar
• Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.Muscle Nerve 29: 656–662, 2004.
  Article PubMed Google Scholar
• Grondard C, Biondi O, Armand AS et al. Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse.J Neurosci 25: 7615–7622, 2005.
  Article PubMed CAS Google Scholar
• Bertini E, Burghes A, Bushby K, et al. 134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy11–13 February 2005, Naarden, The Netherlands.Neuromuscul Disord 15: 802–816, 2005.
  Article PubMed CAS Google Scholar
• Iannaccone ST. Outcome measures for pediatric spinal muscular atrophy.Arch Neurol 59: 1445–1450, 2002.
  Article PubMed Google Scholar
• Iannaccone ST, Hynan LS. Reliability of 4 outcome measures in pediatric spinal muscular atrophy.Arch Neurol 60: 1130–1136, 2003.
  Article PubMed Google Scholar
• Sumner C, Kolb, SJ, Harmison, GG, Jeffries, NO, Schadt, K, Finkel, RS, Dreyfuss, G, Fischbeck, KH. SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials.Neurology, in press.